Efficacy Verification Testing for Cosmetic Formulations: Methods, Standards, and Claim Substantiatio

Efficacy verification testing for cosmetic formulations provides the objective scientific evidence required to substantiate performance claims such as moisturization, anti-aging, brightening, and sun protection. By combining instrumental bioengineering measurements, in-vitro laboratory assays, controlled human clinical trials, and consumer perception studies, brands can satisfy the stringent regulatory requirements of China, the European Union, and other major markets. This article explains the sample types, testing items, methodologies, applicable standards, and practical applications involved in verifying the efficacy of cosmetic formulations.

Technical Overview

Efficacy verification testing, also known as efficacy claim substantiation, is the systematic evaluation of whether a cosmetic formulation delivers the functional benefits claimed on its label and in its advertising. Because modern cosmetic regulations—including China's Cosmetic Supervision and Administration Regulation (CSAR), the EU Cosmetics Regulation (EC) No 1223/2009, and the common criteria for cosmetic claims defined in Commission Regulation (EU) No 655/2013—require that claims be supported by adequate and verifiable evidence, efficacy testing has become an essential step in product development and market registration.

A complete efficacy evaluation typically integrates multiple tiers of evidence: physicochemical and in-vitro laboratory data, non-invasive instrumental skin measurements, controlled human clinical trials, and consumer self-assessment studies. The strength of a claim is generally proportional to the quality and relevance of this evidence, with in-vivo instrumental data from statistically powered panels regarded as the most persuasive. All human studies must be reviewed by an ethics committee, conducted under informed consent, and performed by accredited third-party laboratories or qualified research institutions.

Testing Samples

Skin Care Formulations

Emulsion systems such as creams and lotions, serums and essences, toners, facial masks, eye creams, and hand and body lotions are evaluated for hydration, barrier repair, anti-aging, brightening, sebum-control, and soothing claims.

Sun Care Formulations

Sunscreen lotions, creams, sprays, sticks, and after-sun products are tested for SPF, UVA protection factor, critical wavelength, broad-spectrum status, and water resistance.

Color Cosmetics with Treatment Claims

Foundations, BB and CC creams, tinted moisturizers, and lip products carrying skincare claims such as long-lasting hydration, brightening, or anti-pollution protection.

Hair and Scalp Products

Shampoos, conditioners, hair masks, scalp serums, and anti-hair-loss tonics assessed for cleansing performance, conditioning, strengthening, and density-related benefits.

Special and Functional Claim Products

Anti-acne products, whitening and spot-fading products, deodorants, slimming and firming body products, and products formulated for sensitive skin.

Test samples should originate from pilot or production-scale batches of the final market formulation, with microbiological and stability compliance confirmed prior to testing. Typical submission quantities range from a few hundred grams for instrumental studies to one kilogram or more for full clinical panels and SPF testing.

Testing Items

Testing items are defined by the specific efficacy claims intended for the product label and are grouped into the following categories:

• Stratum corneum hydration and moisturizing durability over 2 to 24 hours
• Transepidermal water loss (TEWL) reduction and skin barrier repair
• Skin elasticity, firmness, and dermal density improvement
• Wrinkle depth, length, and overall skin roughness reduction (anti-wrinkle)
• Melanin index, pigmented spot area, and skin tone evenness (whitening and brightening)
• Sebum secretion rate and facial glossiness reduction (oil control)
• Visible pore count and pore area reduction (pore refinement)
• Erythema index and skin redness reduction (soothing and anti-sensitivity)
• Inflammatory and non-inflammatory acne lesion counts (anti-acne)
• SPF, UVA-PF, critical wavelength, and water resistance (sun protection)
• Antioxidant capacity and anti-pollution protective effects
• Hair tensile strength, breakage rate, combing force, and hair density changes measured by phototrichogram
• Cleansing and makeup-removal efficacy
• Body circumference and skin surface texture improvement (slimming and firming)
• Sensory attributes and consumer-perceived efficacy

Testing Methods

Instrumental Bioengineering Skin Measurements

Non-invasive instruments quantify skin parameters objectively under controlled environmental conditions, typically 20 to 22 °C and 40 to 60 percent relative humidity after 15 to 30 minutes of subject acclimatization. Common techniques include corneometry for capacitance-based stratum corneum hydration, open- or closed-chamber TEWL probes for barrier function, cutometry for suction-based viscoelastic parameters, mexametry for melanin and erythema indices, and sebumetry for sebum quantification. High-frequency ultrasound assesses dermal density, 3D fringe-projection and structured-light topography imaging measure wrinkle depth and skin roughness, and standardized cross-polarized and UV photography documents pigmented spots, pores, and photo-damage progression over time.

Human Clinical Efficacy Trials

Clinical trials follow randomized, single- or double-blinded designs, frequently vehicle-controlled or benchmark-controlled, with panels commonly ranging from 30 to 60 subjects for skin-care claims. Study designs include single-application protocols for immediate effects such as 2 to 8 hour hydration kinetics, as well as long-term use trials of 28 to 84 days with intermediate evaluation time points. Inclusion and exclusion criteria, dosing (typically 2 mg/cm²), and application sites are pre-defined in the protocol, and results are statistically analyzed against baseline and controls using paired t-tests or analysis of variance (ANOVA).

In-Vitro and Ex-Vivo Laboratory Methods

Cell-based assays using human dermal fibroblasts, keratinocytes, and melanocytes quantify biomarkers such as type I collagen synthesis, MMP-1 inhibition, filaggrin and ceramide expression, melanin content, and tyrosinase activity. Enzyme inhibition models targeting elastase, collagenase, hyaluronidase, and alpha-glucosidase, together with chemical antioxidant assays including DPPH, ABTS, FRAP, and ORAC, are used to screen active ingredients and support mechanistic claims. Reconstructed human epidermis (3D skin models) and Franz diffusion cells serve barrier function, permeation, and photoprotection studies, while in-vitro SPF and UVA-PF measurements on PMMA substrates are conducted in accordance with ISO 24443.

Sun Protection Testing

In-vivo SPF is determined per ISO 24444 by comparing the minimal erythema dose (MED) on protected versus unprotected skin using panels of 10 to 20 subjects and a standardized application rate of 2 mg/cm². The in-vivo UVA protection factor based on persistent pigment darkening is measured per ISO 24442, and in-vitro UVA-PF and critical wavelength results per ISO 24443 substantiate broad-spectrum claims. Water resistance is verified after standardized 40- or 80-minute immersion protocols, with the labeled SPF required to be retained at a defined minimum percentage of its initial value.

Consumer Perception and Sensory Studies

Self-assessment questionnaires administered at defined intervals capture perceived efficacy, texture, absorption, and comfort, typically involving 60 to 120 participants under real-use conditions. Trained sensory panels evaluate attributes such as spreadability, greasiness, and after-feel using standardized descriptive scales. These studies add a consumer-relevant dimension that complements instrumental and clinical data within the overall evidence dossier.

Complementary Claim Support Testing

Human repeat insult patch testing (HRIPT) and dermatologist-supervised in-use tests substantiate claims such as dermatologist-tested or suitable for sensitive skin, while ophthalmologist-supervised testing supports claims for eye-area products. These studies are frequently conducted in parallel with efficacy protocols to assemble a complete and internally consistent claim dossier.

Applications

Efficacy verification results serve multiple business and regulatory functions across the product lifecycle:

• Regulatory registration and filing dossiers for market entry in China, the European Union, and other jurisdictions requiring substantiated efficacy data
• Advertising and label claim substantiation to satisfy advertising authorities and reduce legal and compliance risk
• Research and development optimization, including active ingredient screening, dose-finding, and benchmarking against competitor products
• Scientific marketing communication supported by quantified, statistics-backed performance data
• Multi-market export compliance, where a single well-designed test battery can support dossiers across several regions
• Post-market surveillance and quality assurance, confirming that production batches continue to deliver the performance established during development

FAQ

How long does efficacy verification testing take?

Single-application studies can be completed within a few days once the panel is recruited, while long-term clinical trials typically require 4 to 12 weeks of product use. Including recruitment, testing, and statistical reporting, overall project timelines usually range from 6 to 16 weeks.

Which claims require human testing in China?

Under China's efficacy claim evaluation regulations, sun protection, whitening and spot-fading, and anti-hair-loss claims must be verified through human efficacy trials conducted at institutionally qualified laboratories. Most other claims require laboratory data from in-vitro, ex-vivo, or human testing, or consumer-use studies, while simple moisturizing claims may in certain defined cases rely on literature review.

What panel sizes and sample quantities are needed?

Skin-care clinical studies commonly enroll 30 to 60 subjects, ISO 24444 SPF testing uses 10 to 20 subjects, and consumer perception studies typically involve 60 to 120 participants. Sample submission quantities generally range from 500 grams to 2 kilograms depending on the study design and duration.

Can in-vitro data alone substantiate a claim?

In-vitro data are valuable for ingredient screening and mechanistic support, but most regulators and advertising authorities expect instrumental measurements and/or clinical human evidence for consumer-facing performance claims. A combined evidence strategy is therefore the recommended best practice.

Which standards and regulations govern efficacy testing?

Key references include ISO 24444, ISO 24442, and ISO 24443 for sun protection evaluation, Commission Regulation (EU) No 655/2013 for the EU common criteria on cosmetic claims, China's technical specifications for cosmetic efficacy claim evaluation issued under CSAR, and applicable GB/T and EN standards for specific methods.

How are test results used in dossiers and marketing?

Final deliverables typically include a study report with methodology, statistics, baseline-corrected results, ethics approval documentation, and photographic evidence. Marketing and label copy must accurately reflect exactly what the evidence demonstrates, avoiding any exaggeration beyond the tested parameters.